Asahi Kasei Pharma

Asahi Kasei Pharma 的所有者是 Asahi Kasei.

是其中之一......

• Forbes Global 2000 (#1284);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Asahi Kasei 是一家在股票代码 3407 (JP) 下上市的公司。

Asahi Kasei 在 9 个国家有直接业务。

Asahi Kasei 拥有 22家子公司，其中包括 Asahi Kasei Construction、Asahi Kasei Homes 和 Asahi Kasei Medical。

他们在：

• 医疗设备30%
• 化学13%
• 其他57%

查看带有其 18 名主要高管的组织结构图

Asahi Kasei Pharma 搜索最多的简介

• Yoshikazu Aoki, President & Representative Director and Presidenti...
• Shuichi Sakamoto, Chairman and Director
• Hiroki Ideguchi, Executive Officer

创建提醒
跟踪 Asahi Kasei Pharma 的高管变动

Asahi Kasei 拥有 1,829 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。

Popular M&A news in 药店

• Revance Therapeutics has announced the acquisition of Revance Therapeutics  (公布2025一月14号).
• Stemtech and Seacret Direct have announced they will merge  (公布2024十二月5号)..
• Recursion Pharma and Exscientia have merged  (公布2024十一月27号)..

药店 行业的其他推荐联系人

• Adare Pharmaceuticals 企业 Kristin Berkinsky - Chief Human Resources Officer
• Amneal Pharmaceuticals 企业 Paul Meister - Chairman of the Board
• Braeburn Pharmaceuticals 企业 Seth Harrison - Chairman and Director

了解更多有关药店行业的信息 >

Asahi Kasei Pharma 的最新新闻稿

• Asahi Kasei receives governmental support to expand manufacturing capacity for green hydrogen production equipment in Japan | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• Car users’ concerns to define interior of fully autonomous cars, citing 5th Global Automotive Consumer Survey by Asahi Kasei | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• Asahi Kasei receives 2024 TSMC Excellent Performance Award in recognition of its Pimel™ photosensitive dielectric for advanced semiconductor packaging | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• Licensee of Asahi Kasei technology begins commercial production of high-purity carbonates using CO2 as main feedstock in China | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• AKM starts mass production and shipment of its smallest and thinnest Hall element for high-precision position detection | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• Issuance of unsecured straight bonds | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• Chiome Bioscience and Asahi Kasei Pharma Enter into Exclusive License Agreement for anti-CX3CR1 antibody | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• Asahi Kasei Battery Separator Corporation Breaks Ground on Lithium-ion Battery Separator Plant in the Niagara Region | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• Notice of decision to discontinue acrylonitrile and other operations of equity-method affiliate PTT Asahi Chemical Co., Ltd. | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• Announcement of listing on the NHI drug price standard and marketing of Cresemba™ Capsule 40 mg in Japan | 2024 | News | Asahi KaseiBack ButtonSearch IconFilter Icon
• View more press releases Close

关于 Asahi Kasei Pharma 的社交媒体

• Asahi Kasei Pharma 在 维基百科、谷歌新闻 和 雅虎财经
• Asahi Kasei Pharma 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Yoshikazu Aoki

致电Asahi Kasei Pharma，电话：+81 33...

查看组织结构图

Register to receive your alert

报告错误